EpiHeart
PrivateLast Round
Early Funding
May 1, 2024
Est. Valuation
$5.6M
Total Funding Raised
$740,000
Momentum Score
50 /100
Company Overview
EpiHeart is a medical device company that provides a Cardiac Micrograft Therapy™ treatment to stimulate cardiac tissue recovery and improve heart function.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Biotechnology, Clinical Trials, Biotech Equipment, Precision Medicine
Business Model
B2B
Customer Profile
Hardware Sales, Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
EpiHeart Comps
Public and private peers based on sector, stage, and business model.
EpiHeart Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Early Funding | May 1, 2024 | ||||
| Seed | Feb 22, 2021 | ||||
| Accelerator | Jun 8, 2020 |
EpiHeart Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| SPARK Finland | Accelerator |
| Health Incubator Helsinki | Accelerator, Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 15, 2026
Monthly visitors increased 885% MoM, reaching 1.6K.
- Jan 20, 2026
Monthly visitors grew 962% MoM, reaching 913.
EpiHeart Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about EpiHeart's valuation, stock price, and market status.
